{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T18:52:38Z","timestamp":1777315958245,"version":"3.51.4"},"reference-count":23,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Annals of Clinical Psychiatry"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.12788\/acp.0012","type":"journal-article","created":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T10:14:29Z","timestamp":1604225669000},"page":"275-280","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":16,"title":["Kratom: A Growing Substance of Abuse in the United States"],"prefix":"10.1177","volume":"32","author":[{"given":"Daniel Stephen","family":"Demick","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences University of Louisville School of Medicine Louisville, Kentucky, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taelor T.","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences University of Louisville School of Medicine Louisville, Kentucky, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey T.","family":"Summers","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences University of Louisville School of Medicine Louisville, Kentucky, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rif S. El","family":"Mallakh","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences University of Louisville School of Medicine Louisville, Kentucky, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2020,11]]},"reference":[{"key":"e_1_3_2_2_2","first-page":"1","article-title":"Complementary and alternative medicine use among adults and children: United States, 2007","volume":"12","author":"Barnes PM","year":"2008","unstructured":"BarnesPM BloomB NahinRL . Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report. 2008; 12: 1\u201323.","journal-title":"Natl Health Stat Report."},{"key":"e_1_3_2_3_2","first-page":"1125","volume-title":"Basic and clinical pharmacology, 12th ed.","author":"Denneky CE","unstructured":"DennekyCE TsourounisC Dietary supplements & herbal medications. In: KatzungB MastersS TrevorA eds. Basic and clinical pharmacology, 12th ed. New York, NY: McGraw Hill; 2011: 1125\u20131137."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1811055"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2018.12.038"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/B978-0-12-800634-4.00089-5","volume-title":"Neuropathology of drug addictions and substance misuse: general processes and mechanisms, prescription medications, caffeine and areca, polydrug misuse, emerging addictions and non-drug addictions","author":"Bergen-Cico D","year":"2016","unstructured":"Bergen-CicoD MacClurgK. Kratom (Mitragyna speciosa): use, addiction potential, and legal status. In: PreedyVR ed. Neuropathology of drug addictions and substance misuse: general processes and mechanisms, prescription medications, caffeine and areca, polydrug misuse, emerging addictions and non-drug addictions, Volume 3. Amsterdam, Netherlands: Elsevier; 2016: 903\u2013911."},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2008.02209.x"},{"issue":"1","key":"e_1_3_2_8_2","first-page":"140","article-title":"OR03-1. Effect of krathom (Mitragyna speciosa Korth.) use among traditional users in Southern Thailand","volume":"49","author":"Saingam D","year":"2014","unstructured":"SaingamD AssanangkornchaiS GeaterA. OR03-1. Effect of krathom (Mitragyna speciosa Korth.) use among traditional users in Southern Thailand. Alcohol Alcoholism. 2014, 49(suppl 1):140.","journal-title":"Alcohol Alcoholism."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijerphl6020177"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2013.854153"},{"key":"e_1_3_2_11_2","unstructured":"Controlled Substance Scheduling - Kratom. Columbus OH: The Common Sense Initiative -Ohio; 2019. https:\/\/www.americankratom.org\/images\/CSI.BIA.Ohio.pdf. Accessed June 30 2020."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.6b00360"},{"key":"e_1_3_2_13_2","unstructured":"CalveyTN WilliamsNE. Principles and practice of pharmacology for anaesthetists 5th ed. Maiden MA: Blackwell Publications; 2008."},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.cell.2006.01.029","article-title":"A nuclear function of beta-arrestinl in GPCR signaling: regulation of histone acetylation and gene transcription","volume":"124","author":"Kang J","year":"2006","unstructured":"KangJ ShiY XiangB . A nuclear function of beta-arrestinl in GPCR signaling: regulation of histone acetylation and gene transcription. Cell. 2006; 124: 833\u2013847.","journal-title":"Cell"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2019.111876"},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1080\/15563650.2019.1569236","article-title":"Kratom exposures reported to United States poison control centers: 2011-2017","volume":"57","author":"Post S","year":"2019","unstructured":"PostS SpillerHA ChounthirathT . Kratom exposures reported to United States poison control centers: 2011-2017. Clin Toxicol (Phila). 2019; 57: 847\u2013854.","journal-title":"Clin Toxicol (Phila)."},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/sj.bjp.0706661","article-title":"Differential activation of G-proteins by mu-opioid receptor agonists","volume":"147","author":"Saidak Z","year":"2006","unstructured":"SaidakZ Blake-PalmerK HayDL . Differential activation of G-proteins by mu-opioid receptor agonists. Br J Pharmacol. 2006; 147: 671\u2013680.","journal-title":"Br J Pharmacol"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/j.jmb.2017.05.009","article-title":"Drug binding poses relate structure with efficacy in the \u00ce\u00bc opioid receptor","volume":"429","author":"Sutcliffe KJ","year":"2017","unstructured":"SutcliffeKJ HendersonG KellyE . Drug binding poses relate structure with efficacy in the \u00ce\u00bc opioid receptor. J Mol Biol. 2017; 429: 1840\u20131851.","journal-title":"J Mol Biol"},{"key":"e_1_3_2_19_2","first-page":"792","article-title":"Pharmacology of kratom: an emerging botanical agent with stimulant, analgesic and opioid-like effects","volume":"112","author":"Prozialeck WC","year":"2012","unstructured":"ProzialeckWC JivanJK AndurkarSV Pharmacology of kratom: an emerging botanical agent with stimulant, analgesic and opioid-like effects. J Am Osteopath Assoc. 2012; 112: 792\u2013799.","journal-title":"J Am Osteopath Assoc."},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"748","DOI":"10.15585\/mmwr.mm6529a4","article-title":"Notes from the field: kratom (Mitragyna speciosa) exposures reported to poison centers - United States, 2010-2015","volume":"65","author":"Anwar M","year":"2016","unstructured":"AnwarM LawR SchierJ. Notes from the field: kratom (Mitragyna speciosa) exposures reported to poison centers - United States, 2010-2015. MMWR Morbid Mortal Weekly Rep. 2016; 65: 748\u2013749.","journal-title":"MMWR Morbid Mortal Weekly Rep."},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.13m08725"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2019.111876"},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/ADM.0000000000000435","article-title":"Treatment of kratom withdrawal and addiction with buprenorphine","volume":"12","author":"Khazaeli A","year":"2018","unstructured":"KhazaeliA JerryJM VazirianM. Treatment of kratom withdrawal and addiction with buprenorphine. J Addiction Med. 2018; 12: 493\u2013495.","journal-title":"J Addiction Med"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2020.1773586"}],"container-title":["Annals of Clinical Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.12788\/acp.0012","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.12788\/acp.0012","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.12788\/acp.0012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:06:20Z","timestamp":1757610380000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.12788\/acp.0012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["10.12788\/acp.0012"],"URL":"https:\/\/doi.org\/10.12788\/acp.0012","relation":{},"ISSN":["1040-1237","1547-3325"],"issn-type":[{"value":"1040-1237","type":"print"},{"value":"1547-3325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11]]}}}